Many biopharma teams are operating on analytics that were configured once and never fully validated. Conversion rates don't make sense. Reporting doesn't align with business outcomes. PharmaForward builds the measurement foundation that makes every other decision reliable.
HIPAA limits what can be tracked. MLR review creates delays that mean tags are often wrong by the time they launch. Agencies implement GA4 to check a box, not to answer a question.
The result looks complete — sessions, conversions, cost-per-click — but doesn't connect to what the business is actually trying to achieve. How many patients found a treatment center? How many HCPs requested a rep? What is a treatment center search worth?
PharmaForward starts from the question your leadership actually needs answered — not from the data that's easiest to collect.
Your CVR looks high but nobody believes it. Double-counted micro-events, GA4-imported conversions, and misconfigured goals are the most common causes. We find them, document them, and fix them.
You have dashboards but no answers. Session counts and CTR tell you what happened. PharmaForward builds pharma marketing analytics that tells you why — and what to change.
You can't connect spend to outcomes. Without a proxy ROAS model, every budget conversation is a negotiation based on impressions. We assign dollar values to conversion events so every channel has an ROI number.
Your agencies report, but don't diagnose. Monthly summaries describe what happened. PharmaForward explains why — and recommends what to change before the next reporting cycle.
Cross-domain tracking is broken. Patients move between brand sites and support portals. Without cross-domain configuration, every session looks new and attribution breaks. We fix this at the GTM architecture level.
Every layer of the measurement stack — built within HIPAA, GDPR, and MLR requirements from day one.
When PharmaForward inherited this account, it reported a 76.21% conversion rate. That number had been used to optimize Smart Bidding, allocate budget, and brief leadership for months. It was wrong.
GA4-imported conversions were double-counting micro-events. The HCP campaigns sat in the patient account. Parallel tracking had corrupted historical data. The program had been optimizing against a measurement layer that bore no relation to reality.
Phase one: full measurement rebuild — eight conversion actions recreated from scratch, native tags validated, and a proxy ROAS model built assigning dollar values to treatment center searches and patient support enrollments. Phase two: Smart Bidding migration once thirty days of clean data had accumulated. Within ninety days, proxy ROAS more than doubled.
Two to four weeks. Every tag, trigger, variable, and conversion action examined. Data quality scored. The gap between what your measurement reports and what's actually happening documented precisely.
Clean implementation from scratch or targeted remediation. Cross-domain tracking, consent management, HIPAA-aware configuration, conversion deduplication — built correctly, documented for your MLR team.
Dollar values assigned to your specific conversion events — treatment center searches, HCP rep requests, patient support enrollments. Every channel gets an ROI number. Budget conversations get a foundation.
Weekly KPI pulse reports, real-time dashboards, monthly strategic analysis. The measurement layer is not a project — it's a system that stays current as campaigns change, platforms update, and MLR requirements evolve.
The questions biopharma analytics and marketing teams ask most often — answered directly.
Related: AI & Search Visibility · Marketing Optimization
Two to four weeks across your biopharma properties. You’ll know exactly what’s broken and what it’s costing.
Connect with us